Treatment Of Anemia With Erythropoietin May Benefit Heart Failure Patients
This medical News / Journal title : :Treatment Of Anemia With Erythropoietin May Benefit Heart Failure Patients
Heart failure patients may benefit from treatment of anaemia similarly to those with chronic kidney disease (CKD) or cancer. Anaemia is common to many diseases (chronic kidney disease, cancer, chronic heart failure) as well as a consequence of treatment for diseases such as cancer, specifically with chemotherapeutic agents.
Read Full about this medical News / resources
- Heart Failure Device Leads To 70 Percent Improvement For Women; Double The Benefit Of Men
- Short-Term Kidney Failure In Heart Patients May Not Be As Detrimental As Previously Thought
- Intravenous Administration Of Endometrial Regenerative Cells (ERC) Induces Benefit In Heart Failure Patient
- Do Cognitive Problems Hamper Heart Failure Patients?
- ARCA Biopharma Announces Patent Issued For Treating Heart Failure Patients With Bucindolol Based On Genetic Testing
- Methods For The Diagnosis Of Heart Failure Reviewed
- Compound Shows Promise Against Intractable Heart Failure
- Failing Heart, Failing Kidney: Double Trouble?
- Heart Failure: More Or Less Malignant Than Cancer?
- ESC Heart Failure Meeting Encourages Audience Interaction
- Juventas Therapeutics Enrolling Phase I Clinical Trial Of JVS-100 For Patients With Heart Failure
- Cellmedicine Stem Cell Clinic Case Report Of Successful Treatment Of Heart Failure Patient Published
- Higher Rate Of Early Follow-up For Heart Failure Patients Linked With Lower Rate Of Readmissions
- The Effectiveness Of Acupuncture For Exercise Tolerance In Heart Failure
- Cure for Aids, Cancer, Heart Disease and All Diseases | Ecommerce …